Lyell Immunopharma, Inc. (LYEL) - Quarterly Balance Statement

Home
LYEL
Financials

0.6635 (USD) • At close January 7, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents Numbers are in millions	100.299	133.424	125.65	145.647	286.214	224.372	109.426	123.554	116.311	205.739	222.596	293.828	393.504	564.441	244.37	140.406	-436.049
Short Term Investments Numbers are in millions	340.248	357.695	400.65	400.576	289.217	371.376	503.343	516.598	531.821	449.825	391.316	320.966	225.417	260.082	360.563	472.213	872.098
Cash and Short Term Investments Numbers are in millions	440.547	491.119	526.3	546.223	575.431	595.748	612.769	640.152	648.132	655.564	613.912	614.794	618.921	824.523	604.933	612.619	436.049
Net Receivables Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Inventory Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Current Assets Numbers are in millions	9.498	8.705	7.865	8.463	11.423	10.662	11.629	11.143	23.226	22.428	23.586	22.984	24.452	20.634	9.604	4.928	0
Total Current Assets Numbers are in millions	450.045	499.824	534.165	554.686	586.854	606.41	624.398	651.295	659.745	666.778	625.705	626.286	631.147	834.84	609.735	617.547	436.049
Non-Current Assets:
Property, Plant & Equipment, Net Numbers are in millions	124.709	130.792	136.531	142.317	148.699	155.189	160.99	166.265	169.811	172.466	171.432	166.639	163.093	158.061	144.874	124.055	0
Goodwill Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Goodwill and Intangible Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments Numbers are in millions	39.112	19.287	19.286	48.507	54.73	68.953	90.179	115.041	144.52	178.439	271.119	330.532	400.959	233.709	118.652	163.443	0
Tax Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets Numbers are in millions	5.349	4.239	4.238	4.519	4.706	4.802	4.883	4.96	3.193	3.991	3.847	3.949	3.135	3.257	3.928	3.235	-436.049
Total Non-Current Assets Numbers are in millions	169.17	154.318	160.055	195.343	208.135	228.944	256.052	286.266	317.524	354.896	446.398	501.12	567.187	395.027	267.454	290.733	-436.049
Total Assets Numbers are in millions	619.215	654.142	694.22	750.029	794.989	835.354	880.45	937.561	977.269	1,021.674	1,072.103	1,127.406	1,198.334	1,229.867	877.189	908.28	0
Liabilities & Equity:
Current Liabilities:
Account Payables Numbers are in millions	3.596	4.199	4.895	4.817	4.365	5.805	5.733	3.917	4.795	4.247	6.51	3.207	3.526	4.863	7.121	9.396	0
Short Term Debt Numbers are in millions	0	0	0	6.273	0	0	0	4.534	0	0	0	1.169	0	0	0	3.617	0
Tax Payables Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Numbers are in millions	0	0	0	20.36	-6.061	-5.853	-4.81	21.869	11.191	15.426	6.224	4.988	5.581	8.226	7.916	6.095	0
Other Current Liabilities Numbers are in millions	29.916	26.68	27.458	23.429	30.699	28.585	25.064	28.577	35.231	30.618	28.321	37.374	50.174	50.574	41.775	30.177	0
Total Current Liabilities Numbers are in millions	33.512	30.879	32.353	34.519	35.064	34.39	30.797	37.028	51.217	50.291	41.055	46.738	59.281	63.663	56.812	49.285	0
Non-Current Liabilities:
Long Term Debt Numbers are in millions	51.441	106.646	110.318	56.894	117.152	120.442	123.652	126.336	64.636	132.148	134.95	133.3	131.368	122.942	57.756	50.957	0
Deferred Revenue Non-Current Numbers are in millions	0	0	0	0	0	0	0	0	37.163	32.927	77.871	79.665	81.883	81.878	84.808	89.066	0
Deferred Tax Liabilities Non-Current Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities Numbers are in millions	3.565	-49.884	-51.608	3.664	-54.8	-56.333	-57.825	-59.055	4.227	-61.734	-63.022	-62.084	-60.672	-60.571	0.893	89.598	0
Total Non-Current Liabilities Numbers are in millions	55.006	56.762	58.71	60.558	62.352	64.109	65.827	67.281	106.026	103.341	149.799	150.881	152.579	144.249	143.457	140.555	0
Total Liabilities Numbers are in millions	88.518	87.641	91.063	95.077	97.416	98.499	96.624	104.309	157.243	153.632	190.854	197.619	211.86	207.912	200.269	189.84	0
Equity:
Preferred Stock Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	1,198.334	1,229.867	1,010.968	1,010.968	519.163
Common Stock Numbers are in millions	0.026	0.026	0.025	0.025	0.025	0.025	0.025	0.025	0.025	0.025	0.025	0.024	0.024	0.024	0.002	0.002	0
Retained Earnings Numbers are in millions	-1,153.171	-1,108.588	-1,062.779	-1,002.112	-949.182	-898.329	-834.439	-767.48	-759.083	-688.829	-652.506	-584.362	-500.656	-451.781	-389.186	-334.143	0
Accumulated Other Comprehensive Income/Loss Numbers are in millions	0.76	-0.397	-0.404	-0.094	-1.181	-2.379	-3.879	-7.599	-9.996	-8.351	-6.6	-1.623	-0.065	0.073	0.163	0.256	-111.108
Other Total Stockholders Equity Numbers are in millions	1,683.082	1,675.46	1,666.315	1,657.133	1,647.911	1,637.538	1,622.119	1,608.306	1,589.08	1,565.197	1,540.33	1,515.748	1,487.171	1,473.639	54.973	41.357	0
Total Shareholders Equity Numbers are in millions	530.697	566.501	603.157	654.952	697.573	736.855	783.826	833.252	820.026	868.042	881.249	929.787	986.474	1,021.955	676.92	718.44	408.055
Total Equity Numbers are in millions	530.697	566.501	603.157	654.952	697.573	736.855	783.826	833.252	820.026	868.042	881.249	929.787	986.474	1,021.955	676.92	718.44	408.055
Total Liabilities & Shareholders Equity Numbers are in millions	619.215	654.142	694.22	750.029	794.989	835.354	880.45	937.561	977.269	1,021.674	1,072.103	1,127.406	1,198.334	1,229.867	877.189	908.28	408.055

Lyell Immunopharma, Inc.

NASDAQ:LYEL Add to watchlist

NASDAQ:LYEL